NCT05679414|Completed
Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients
(MTHFR)C677T
Loading search results
(MTHFR)C677T
Sponsor study identifier
observational
46
1 country
1
Study Start
May 11, 2022
Actual (reported)Primary Completion
November 30, 2022
Actual (reported)Study Completion
November 30, 2022
Actual (reported)Aim of the study is to find the prevalence of thrombophilic gene methylene tetrahydrofolate reductase (MTHFR) gene polymorphism in a sample of COVID-19 patients, aiming at early detection of MTHFR mutant patients and guiding preventive therapy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 30, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 11, 2022
Actual (reported)November 30, 2022
Actual (reported)November 30, 2022
Actual (reported)January 9, 2023
Actual (reported)January 11, 2023
Actual (reported)development of vascular thrombotic manifestation
Level of D. dimer, Lower Limb duplex, or CT chest with Puplomary Angiography if needed.
4 weeks
Covid 19 patients in which MTHFR C677T genotypes was determined by RT- PCR of 2 ml EDTA blood sample.Follow up patient for 28 days as regard development of vascular thrombotic manifestation
Healthy subjects in which MTHFR C677T genotypes was determined by RT- PCR of 2 ml EDTA blood sample.
Venous blood sample
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients diagnosed as COVID -19 by RT-PCR
Ain Shams University
Cairo, +2, Egypt
Eman B AbdelFattah, MD
Ain Shams University
46 participants (actual enrollment reported by the registry).
First Submitted
January 9, 2023
First Posted
January 11, 2023
Study Start
May 11, 2022
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
November 30, 2022
Actual (reported)Study Completion
November 30, 2022
Actual (reported)Last Updated
January 11, 2023
Record last verified: 2023-01
All IPD that underlie results in a publication maybe shared
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: